Atrial Fibrillation Modifies the Relationship Between Beta Blocker Dose and Physical Capacity After Myocardial...

Area of Science:

• Cardiology
• Exercise Physiology

Background:

• Atrial fibrillation (AF) is a common arrhythmia in patients recovering from myocardial infarction (MI).
• Beta-adrenergic signaling and heart rate-controlling medications can impact functional capacity in these patients.

Purpose of the Study:

• To investigate the influence of atrial fibrillation (AF) and beta-blocker therapy on functional capacity in post-myocardial infarction (MI) patients undergoing cardiac rehabilitation (CR).

Main Methods:

• Retrospective analysis of 117 male post-MI patients in outpatient CR.
• Functional capacity assessed using the 6-minute walk test (6MWT).
• AF presence and carvedilol-equivalent beta-blocker dose were recorded.

Main Results:

• Patients with AF were older and had significantly lower 6MWT distances compared to those without AF.
• AF was independently associated with reduced functional capacity.
• A significant interaction between beta-blocker dose and AF was observed, with beta-blockers positively associated with 6MWT only in patients with AF.

Conclusions:

• Atrial fibrillation identifies a subgroup of post-MI patients with markedly reduced functional capacity in early CR.
• The relationship between beta-blocker dosage and exercise capacity differs based on cardiac rhythm.
• Further prospective studies are needed to confirm these preliminary findings.